Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure–Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)
Nadezhda German, Ann M. Decker, Brian P. Gilmour, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 18, pp. 7758-7769
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor
Thuy Nguyen, Jun‐Xu Li, Brian F. Thomas, et al.
Medicinal Research Reviews (2016) Vol. 37, Iss. 3, pp. 441-474
Open Access | Times Cited: 89
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen, Brian F. Thomas, Yanan Zhang
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 16, pp. 1418-1435
Open Access | Times Cited: 85
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review
Paula Morales, Pilar Goya, Nadine Jagerovic, et al.
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 22-30
Open Access | Times Cited: 84
Structural Insights into CB1 Receptor Biased Signaling
R.M. Al-Zoubi, Paula Morales, Patricia H. Reggio
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1837-1837
Open Access | Times Cited: 75
Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities
Leepakshi Khurana, Ken Mackie, Daniele Piomelli, et al.
Neuropharmacology (2017) Vol. 124, pp. 3-12
Open Access | Times Cited: 72
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Lu Hou, Jian Rong, Ahmed Haider, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 123-149
Open Access | Times Cited: 51
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)
Pushkar M. Kulkarni, Abhijit Kulkarni, Anisha Korde, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 1, pp. 44-60
Open Access | Times Cited: 53
Scalable, One-Pot, Microwave-Accelerated Tandem Synthesis of Unsymmetrical Urea Derivatives
Abhijit Kulkarni, Sumanta Garai, Ganesh A. Thakur
The Journal of Organic Chemistry (2016) Vol. 82, Iss. 2, pp. 992-999
Closed Access | Times Cited: 49
Development of Squaramides as Allosteric Modulators of the CB1 Receptor: Synthesis, Computational Studies, Biological Characterization, and Effects against Cocaine-Induced Behavioral Sensitization and Reinstatement in Rats
Thuy Nguyen, Ann M. Decker, Daniel G. Barrus, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
Dai Lu, Sri Sujana Immadi, Zhixing Wu, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 324-335
Open Access | Times Cited: 39
Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias
Jamie J. Manning, Hayley M. Green, Michelle Glass, et al.
Neuropharmacology (2021) Vol. 193, pp. 108611-108611
Closed Access | Times Cited: 30
Pyrimidinyl Biphenylureas: Identification of New Lead Compounds as Allosteric Modulators of the Cannabinoid Receptor CB1
Leepakshi Khurana, Boqiao Fu, Anantha Lakshmi Duddupudi, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 3, pp. 1089-1104
Open Access | Times Cited: 39
Iridium‐Catalyzed [2+2+2] Cycloaddition of α,ω‐Diynes with Cyanamides
Toru Hashimoto, Satoshi Ishii, Reiko Yano, et al.
Advanced Synthesis & Catalysis (2015) Vol. 357, Iss. 18, pp. 3901-3916
Closed Access | Times Cited: 38
Synthesis and molecular docking of N′-arylidene-5-(4-chlorophenyl)-1-(3,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbohydrazides as novel hypoglycemic and antioxidant dual agents
Eduardo Hernández‐Vázquez, Sandybel Salgado-Barrera, Juan José Ramírez‐Espinosa, et al.
Bioorganic & Medicinal Chemistry (2016) Vol. 24, Iss. 10, pp. 2298-2306
Closed Access | Times Cited: 38
Structure–activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators
Thuy Nguyen, Nadezhda German, Ann M. Decker, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 9, pp. 2195-2203
Open Access | Times Cited: 36
Amination of Aromatic Halides and Exploration of the Reactivity Sequence of Aromatic Halides
Yang Chu, Feng Zhang, Guo‐Jun Deng, et al.
The Journal of Organic Chemistry (2018) Vol. 84, Iss. 1, pp. 181-190
Closed Access | Times Cited: 34
Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity
Rachel Dopart, Dai Lu, Aron H. Lichtman, et al.
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 3-13
Open Access | Times Cited: 33
Allosteric Modulators Targeting Cannabinoid cb1 and cb2 Receptors: Implications for Drug Discovery
Francesca Gado, Serena Meini, Simone Bertini, et al.
Future Medicinal Chemistry (2019) Vol. 11, Iss. 15, pp. 2019-2037
Open Access | Times Cited: 30
Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Angelika Andrzejewska-Romanowska, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5874-5874
Open Access | Times Cited: 30
The future of type 1 cannabinoid receptor allosteric ligands
Mariam Alaverdashvili, Robert B. Laprairie
Drug Metabolism Reviews (2018) Vol. 50, Iss. 1, pp. 14-25
Closed Access | Times Cited: 28
CB1 allosteric modulators and their therapeutic potential in CNS disorders
Catharine A. Mielnik, Vincent Lam, Ruth A. Ross
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110163-110163
Closed Access | Times Cited: 21
The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB 1 receptor allosteric modulators
Thomas F. Gamage, Charlotte E. Farquhar, Timothy W. Lefever, et al.
Neuropharmacology (2017) Vol. 125, pp. 365-375
Open Access | Times Cited: 24
Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution
Thuy Nguyen, Nadezhda German, Ann M. Decker, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 17, pp. 7410-7424
Open Access | Times Cited: 24
Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target
David R. Janero, Ganesh A. Thakur
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 12, pp. 1223-1237
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top